BMEDvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BMED, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/16/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED ETF 2 | +3.05%– | +12.16%– | +14.51%– | +24.44%– | +54.98%– | +20.00%– |
| Flows | BMED ETF 2 | -– | +$1M– | +$5M– | +$6M– | +$7M– | +$6M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED ETF 2 | +21.82%– | +17.81%– | +16.86%– | +18.13%– |
| Max drawdown | BMED ETF 2 | -5.85%– | -14.71%– | -19.76%– | -32.14%– |
| Max drawdown duration | BMED ETF 2 | 31d– | 196d– | 237d– | 1479d– |
Trading data
BMED | ETF 2 | |
Last sale 10/16/2026 at 1:30 PM | $34.55 | – |
| Previous close 10/15/2026 | $35.06 | – |
| Consolidated volume 10/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/16/2026 at 1:30 PM
Live
Closed
BMED | ETF 2 | |
|---|---|---|
| Last price | $34.55 | – |
| 1D performance | -1.45% | – |
| AuM | $13.83 M | – |
| E/R | 0.77% | – |
Characteristics
BMED | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | iShares | – |
| Benchmark | - | – |
| N° of holdings | 53 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BMED
USA
87.23%
Other
12.77%
ETF 2
Sectors
BMED
Healthcare
98.95%
Other
1.05%
ETF 2
Advertisement
Diversification
BMED
Total weight of top 15 holdings out of 15
58.7%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
BMED
Gilead Sciences, Inc.
5.01%
Merck & Co., Inc.
4.99%
AbbVie, Inc.
4.61%
Johnson & Johnson
4.27%
Charles River Laboratories International, Inc.
4.22%
Thermo Fisher Scientific, Inc.
4.12%
Edwards Lifesciences Corp.
3.95%
Moderna, Inc.
3.86%
IQVIA Holdings, Inc.
3.72%
Danaher Corp.
3.64%
Vertex Pharmaceuticals, Inc.
3.56%
Waters Corp.
3.53%
Biogen, Inc.
3.45%
Mettler-Toledo International, Inc.
3.16%
DexCom, Inc.
2.61%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
